Pain management in osteoarthritis using the centrally acting analgesics duloxetine and pregabalin - Pain management in osteoarthritis using centrally acting analgesics (DUPRO)

St George's University of London0 个研究点目标入组 45 人开始时间: 2012年8月21日最近更新: 2019年6月30日

适应症

试验速览

暂无简介。

•Participants fulfilling: 1.the American College of Rheumatology (ACR) criteria for the diagnosis of hand osteoarthritis, 2.right or left -handed 3.male or female 4.aged 40-75 5.On usual care for hand osteoarthritis including paracetamol and/or NSAIDs
•Are the trial subjects under 18? no
•Number of subjects for this age range: 0
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 35
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 10

•1. other rheumatological diagnosis e.g. rheumatoid arthritis 2. current or planned pregnancy 3. contraindications to duloxetine or pregabalin such as MAOI, SSRI, antidepressants, oral contraceptives, St John’s wort 4. history of depression 5. concomitant use of opioids including tramadol and pethidine 6. recent surgery i.e < 6 weeks prior to participation in the study 7. recent insertion of surgical implants i.e. less than 6 weeks before participation prior to entry 8. Previous use of duloxetine and/or pregabalin 9. uncontrolled hypertension 10. eGFR < 60 ml/min 11. hepatic impairment defined as ALT > 2.5 X ULN within 6 weeks of last clinical assessment 12. ischaemic heart disease 13. diabetes mellitus 14. regular use of alcohol or alcohol abuse(maximum limits are 28 units/week for men and 21 units/ week for women) 15. lactose intolerance

发起方